Obesity is one of the most pressing public health issues in America, yet it remains one of the most misunderstood and stigmatized. Despite overwhelming evidence that obesity is a chronic, progressive disease — not a simple “lifestyle choice” — millions of people who need treatment face unnecessary roadblocks to care.
Nowhere is this more apparent than in the world of bariatric surgery.
Our very own, Dr. Brian Long, covers this topic in a recent article on ObesityHelp.com.
A new study, recently shared on Good Morning America, on life after weight loss drugs examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications. For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight they lost within a year, according to the review’s analysis.
When researchers used computer statistical modeling to see what could happen after more than a year off the medications, it suggested that those patients could regain about 75% of the weight they had lost.
While weight loss drugs could still be viable option for you, either alone or in conjunction with weight loss surgery, it’s important to have a individualized tailored approach and consider long term outcomes.
Read more: https://abcnews.visitlink.me/2YoelZ
One Secret to Weight Loss Surgery Success? Don’t Go It Alone. Support Groups Are Key to Bariatric Success.
Bariatric surgery offers a transformative opportunity to reclaim health, mobility, and confidence. However, surgery alone isn’t a magic fix. Long-term success hinges on adopting new habits, embracing lifestyle changes, and maintaining ongoing commitment. One of the strongest predictors of success? A supportive community.
A new article from The Washington Post highlights an important reality about GLP-1 weight loss drugs: what happens after the medication stops.
The study found that many former users of Ozempic, Wegovy, and similar drugs regained weight within about 18 months—often four times faster than those relying on diet and exercise alone.
It’s a timely reminder that sustainable weight loss requires more than a temporary solution.
With all the hype surrounding GLP-1 medications, a new Medscape article — “GLP-1s Dominate the Headlines, But Obesity Surgery Wins on Cost” — sheds light on a critical point: although these medications are popular, long-term costs are significantly higher than bariatric surgery, especially due to ongoing monthly pharmacy expenses.
For patients comparing options, surgery delivers greater and more sustained weight-loss at a lower total cost over time. And here’s the part we’re proud of:
Even compared to national averages for bariatric surgery, Nicholson Clinic’s self-pay prices are lower.
That means patients get world-class care, board-certified surgeons, and long-term success — at a cost that’s more accessible than ever.
If you’re exploring weight-loss options, this article is worth the read.
Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people, but a study shows that they’re still not as effective as surgery when it comes to weight loss – and it’s not even close.
Weight loss surgery provides far better results than GLP-1s.
When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who’d undergone bariatric surgery, one method led to much more weight loss.
GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found.
Patients who underwent a sleeve gastrectomy or gastric bypass lost about five times more weight after two years than people who had weekly injections of semaglutide or tirzepatide (the active ingredients in the anti-obesity drugs Wegovy and Zepbound, respectively), researchers reported Tuesday, June 17, at a meeting of the American Society for Metabolic and Bariatric Surgery.
Nearing 50? Obesity Could Steal 10 Years—or More—from Your Life, Says Alarming New Study
There are five classic risk factors for cardiovascular disease — high blood pressure, high cholesterol, obesity, diabetes, and smoking — and at age 50, these factors can reduce life expectancy by more than 10 years.
This is the conclusion of an international study led by German researchers and presented at the 2025 American College of Cardiology Scientific Session.
READ MORE:
5 Risk Factors at 50 Can Steal a Decade of Life
Obesity was tied with 16 common health concerns in a longitudinal cohort study, with the magnitude of risk correlating with the level of obesity.
READ MORE:
https://www.medpagetoday.com/endocrinology/obesity/114842
Sorry, Ozempic users.
Bariatric surgery leads to more weight loss that’s longer-lasting compared to drugs like Ozempic and Wegovy and behavioral changes such as diet and exercise, new research finds.
“Metabolic and bariatric surgery remains the most effective and durable treatment for severe obesity. Unfortunately, it also remains among the most underutilized,” said study co-author and bariatric surgeon Dr. Marina Kurian of NYU Langone Health.
